These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 17904316)

  • 1. Development of PEGylated adenovirus vector with targeting ligand.
    Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
    Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
    Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
    J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses.
    Mok H; Palmer DJ; Ng P; Barry MA
    Mol Ther; 2005 Jan; 11(1):66-79. PubMed ID: 15585407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PEGylated adenovirus for targeted gene therapy.
    O'Riordan CR; Song A
    Methods Mol Biol; 2008; 434():133-60. PubMed ID: 18470643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of adenovirus fiber structure and function on vector development for gene therapy.
    Nicklin SA; Wu E; Nemerow GR; Baker AH
    Mol Ther; 2005 Sep; 12(3):384-93. PubMed ID: 15993650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction.
    Suzuki-Kouyama E; Katayama K; Sakurai F; Yamaguchi T; Kurachi S; Kawabata K; Nakagawa S; Mizuguchi H
    Biomaterials; 2011 Feb; 32(6):1724-30. PubMed ID: 21106235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host responses and persistence of vector genome following intrabronchial administration of an E1(-)E3(-) adenovirus gene transfer vector to normal individuals.
    Harvey BG; Hackett NR; Ely S; Crystal RG
    Mol Ther; 2001 Feb; 3(2):206-15. PubMed ID: 11237677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenovirus vector-mediated gene transfer into stem cells.
    Kawabata K; Sakurai F; Koizumi N; Hayakawa T; Mizuguchi H
    Mol Pharm; 2006; 3(2):95-103. PubMed ID: 16579638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene therapy progress and prospects: adenoviral vectors.
    St George JA
    Gene Ther; 2003 Jul; 10(14):1135-41. PubMed ID: 12833122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of pIX or hexon based on fiberless Ad vectors is not effective for targeted Ad vectors.
    Kurachi S; Koizumi N; Tashiro K; Sakurai H; Sakurai F; Kawabata K; Nakagawa S; Mizuguchi H
    J Control Release; 2008 Apr; 127(1):88-95. PubMed ID: 18258327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immune response induced by gene delivery vectors.
    Sakurai H; Kawabata K; Sakurai F; Nakagawa S; Mizuguchi H
    Int J Pharm; 2008 Apr; 354(1-2):9-15. PubMed ID: 17640834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances towards targetable adenovirus vectors for gene therapy.
    Einfeld DA; Roelvink PW
    Curr Opin Mol Ther; 2002 Oct; 4(5):444-51. PubMed ID: 12435045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Approaches to improving the kinetics of adenovirus-delivered genes and gene products.
    Xu ZL; Mizuguchi H; Sakurai F; Koizumi N; Hosono T; Kawabata K; Watanabe Y; Yamaguchi T; Hayakawa T
    Adv Drug Deliv Rev; 2005 Apr; 57(5):781-802. PubMed ID: 15757761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biophysical targeting of adenovirus vectors for gene therapy.
    Silman NJ; Fooks AR
    Curr Opin Mol Ther; 2000 Oct; 2(5):524-31. PubMed ID: 11249755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity.
    Krasnykh V; Dmitriev I; Navarro JG; Belousova N; Kashentseva E; Xiang J; Douglas JT; Curiel DT
    Cancer Res; 2000 Dec; 60(24):6784-7. PubMed ID: 11156365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Development of pegylated adenovirus vector for cancer gene therapy].
    Eto Y; Yoshioka Y; Asavatanabodee R; Mizuguchi H; Mukai Y; Okada N; Nakagawa S
    Yakugaku Zasshi; 2008 Dec; 128(12):1733-42. PubMed ID: 19043292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer-targeting gene therapy using tropism-modified adenovirus.
    Tanaka T; Kuroki M; Hamada H; Kato K; Kinugasa T; Shibaguchi H; Zhao J; Kuroki M
    Anticancer Res; 2007; 27(6A):3679-84. PubMed ID: 17970028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New complex Ad vectors incorporating both rtTA and tTS deliver tightly regulated transgene expression both in vitro and in vivo.
    Rubinchik S; Woraratanadharm J; Yu H; Dong JY
    Gene Ther; 2005 Mar; 12(6):504-11. PubMed ID: 15660114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A targetable, injectable adenoviral vector for selective gene delivery to pulmonary endothelium in vivo.
    Reynolds PN; Zinn KR; Gavrilyuk VD; Balyasnikova IV; Rogers BE; Buchsbaum DJ; Wang MH; Miletich DJ; Grizzle WE; Douglas JT; Danilov SM; Curiel DT
    Mol Ther; 2000 Dec; 2(6):562-78. PubMed ID: 11124057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.